Work

Prognostic Factors Other Than Age Drive the Risk of Disease Progression in Adults with Burkitt Lymphoma Treated with DA-EPOCH-R

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-147451

Authors: Rahul Lakhotia, Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani, Andrea Nicole Lucas, Seth M. Steinberg, Jonathan W. Friedberg, Brad S. Kahl, Richard F. Little, Nancy L. Bartlett, Michelle A. Fanale, Ariela Noy, Wyndham H. Wilson, Mark Roschewski

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Georgetown University, Massachusetts General Hospital, University of Iowa, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University Health Sciences, University of Rochester Medicine, University of Rochester, Washington University in St. Louis, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3211568546

Cites:

Cited by: 1

Related to: 10